These medications , initially approved for controlling type 2 diabetes , have seen increased use due to their impact on weight loss . This specific drug is a version of semaglutide , which is a GLP-1 receptor https://www.centrale-directe.com/sites/detail/?p=Is-Wegovy-Covered-by-Insurance--Comparing-Costs-with-Mounjaro-for-2026-AbS3SdNZypZbU